The SafeBoosC-III trial and the future of cerebral oximetry-guided interventions in preterm infants-time to pause and reset?

Creator(s)

Krishna Dummula, Children' Mercy HospitalFollow
Vishal Pandey, Children's Mercy HospitalFollow
Venkatesh Sampath, Children's Mercy HospitalFollow

Document Type

Editorial

Publication Date

6-30-2024

Identifier

DOI: 10.21037/tp-24-89; PMCID: PMC11228907

Abstract

Comment on

Cerebral Oximetry Monitoring in Extremely Preterm Infants. N Engl J Med. 2023 Apr 20;388(16):1501-1511. doi: 10.1056/NEJMoa2207554.PMID: 37075142 Clinical Trial.

Journal Title

Transl Pediatr

Volume

13

Issue

6

First Page

1017

Last Page

1021

Keywords

Cerebral oximetry; near-infrared spectroscopy (NIRS); neonatal brain injury

Comments

This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license).

Publisher's Link: https://tp.amegroups.org/article/view/125950/html

Recommended Citation

Dummula K, Pandey V, Sampath V. The SafeBoosC-III trial and the future of cerebral oximetry-guided interventions in preterm infants-time to pause and reset?. Transl Pediatr. 2024;13(6):1017-1021. doi:10.21037/tp-24-89